Wearable device tracks walking patterns to spot dementia risk
NCT ID NCT07127133
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wearable insole and ankle device that measures walking patterns to detect early cognitive decline in older adults. Researchers will collect gait data from 150 participants—some healthy, some with mild cognitive impairment or dementia—first in a lab and then during a week of everyday use at home. The goal is to see if the device can accurately identify people at risk for Alzheimer's disease or related dementias.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
wearable insole and ankle device
What this could lead to
If successful, this could provide a simple, at-home way to detect early cognitive decline, potentially leading to earlier diagnosis and monitoring of Alzheimer's disease.
What could go wrong
This is an early-stage study with only 150 participants, focused on measuring gait accuracy, not on treatment. The device may not reliably distinguish cognitive decline from normal aging or other conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••